Phase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate. [electronic resource]
- Progress in clinical and biological research 1987
- 235-42 p. digital
Publication Type: Journal Article
0361-7742
Aged Antineoplastic Combined Chemotherapy Protocols--therapeutic use Cisplatin--administration & dosage Doxorubicin--administration & dosage Drug Evaluation Fluorouracil--administration & dosage Humans Male Middle Aged Prostatic Neoplasms--drug therapy